Calcium and vitamin D supplements for the treatment and prevention of osteoporosis. Should it be widely used?

Cover Page

Cite item

Full Text

Abstract

Osteoporosis is the most common age-related skeletal diseases, which is characterized by the rapid loss of bone mineral density and increased risk of fragility fractures. The social significance of osteoporosis is attributed to its complications, which increase disability and mortality rates mostly among older people. Inadequate dietary calcium intake and vitamin D deficiency are well-known risk factors for osteoporosis. Thus, for many years, calcium and vitamin D have been considered crucial in the prevention and treatment of osteoporosis. However, in recent years, the efficacy and safety of calcium and vitamin D have been questioned because some randomized clinical trials have reported only a weak positive effect of calcium with or without vitamin on reducing fragility fracture risks. On the contrary, besides the gastrointestinal side effects of calcium supplements and the risk of kidney stones related to the co-administration of calcium and vitamin D supplements, other recent data suggested that calcium supplementation has potential adverse cardiovascular effects. This study focused on the evidence regarding the possible usefulness for bone health and the potential harmful effects of calcium and/or calcium with vitamin D supplementation.

About the authors

Yuliya A. Kaminarskaya

Kliniki Chaika LLC

Author for correspondence.
Email: osipovaulia@gmail.com
ORCID iD: 0000-0002-9893-3292
SPIN-code: 1333-6058

MD

Russian Federation, Moscow

References

  1. Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010;6(2):99–105. doi: 10.1038/nrrheum.2009.260. Erratum in: Nat Rev Rheumatol. 2010;6(4):184.
  2. Aloia J, Bojadzievski T, Yusupov E, et al. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. 2010;95(7):3216–3224. doi: 10.1210/jc.2009-1294
  3. Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(12):827–838. doi: 10.7326/0003-4819-155-12-201112200-00005. Erratum in: Ann Intern Med. 2014;161(8):615–616.
  4. Mirza F, Canalis E. Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol. 2015;173(3):R131–151. doi: 10.1530/EJE-15-0118
  5. Abrahamsen B. The calcium and vitamin D controversy. Ther Adv Musculoskelet Dis. 2017;9(5):107–114. doi: 10.1177/1759720X16685547
  6. Weaver CM, Alexander DD, Boushey CJ, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367–376. doi: 10.1007/s00198-015-3386-5. Erratum in: Osteoporos Int. 2016;27(8):2643–2646.
  7. Kanis JA, Cooper C, Rizzoli R, et al.; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int. 2017;28(7):2023–2034. doi: 10.1007/s00198-017-4009-0. Erratum in: Osteoporos Int. 2017.
  8. Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040. doi: 10.1136/bmj.d2040
  9. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. doi: 10.1136/bmj.c3691
  10. Abrahamsen B, Sahota O. Do calcium plus vitamin D supplements increase cardiovascular risk? BMJ. 2011;342:d2080. doi: 10.1136/bmj.d2080
  11. Cano A, Chedraui P, Goulis DG, et al. Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide. Maturitas. 2018;107:7–12. doi: 10.1016/j.maturitas.2017.10.004
  12. Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ. 2015;351:h3170. doi: 10.1136/bmj.h3170
  13. Belaya ZE, Belova KYu, Biryukova EV, et al. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis and Bone Diseases. 2021;24(2):4–47. (In Russ). doi: 10.14341/osteo12930
  14. Calcium. Fact Sheet for Consumers. National Institutes of Health. Available from: https://ods.od.nih.gov/factsheets/Calcium-Consumer/ Accessed: Dec 2, 2022.
  15. Clinical guideline for the prevention and treatment of osteoporosis. Available from: https://www.nogg.org.uk/full-guideline Accessed: Dec 2, 2022.
  16. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010; 140(4):817–822. doi: 10.3945/jn.109.118539
  17. Giorgini M, Vitale M, Bozzetto L, et al. Micronutrient Intake in a Cohort of Italian Adults with Type 1 Diabetes: Adherence to Dietary Recommendations. J Diabetes Res. 2017:2682319. doi: 10.1155/2017/2682319
  18. Bristow SM, Gamble GD, Horne AM, Reid IR. Dietary calcium intake and rate of bone loss in men. Br J Nutr. 2017;117(10): 1432–1438. doi: 10.1017/S0007114517001301
  19. Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med. 2008;168(20):2276–2282. doi: 10.1001/archinte.168.20.2276
  20. Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med. 1978;92(6):953–963.
  21. Heaney RP, Recker RR, Saville PD. Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr. 1977;30(10):1603–1611. doi: 10.1093/ajcn/30.10.1603
  22. Hunt CD, Johnson LK. Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies. Am J Clin Nutr. 2007;86(4):1054–1063. doi: 10.1093/ajcn/86.4.1054
  23. Kanis JA, Passmore R. Calcium supplementation of the diet – I. BMJ. 1989;298(6667):137–140. doi: 10.1136/bmj.298.6667.137
  24. Bristow SM, Gamble GD, Stewart A, et al. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr. 2014;112(10):1611–1620. doi: 10.1017/S0007114514002785
  25. Jackson RD, LaCroix AZ, Gass M, et al.; Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–683. doi: 10.1056/NEJMoa055218. Erratum in: N Engl J Med. 2006;354(10):1102.
  26. Kim KM, Choi SH, Lim S, et al. Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008–2010). J Clin Endocrinol Metab. 2014;99(7):2409–2417. doi: 10.1210/jc.2014-1006
  27. Tai V, Leung W, Grey A, et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015;351:h4183. doi: 10.1136/bmj.h4183
  28. Seo MH, Kim MK, Park SE, et al. The association between daily calcium intake and sarcopenia in older, non-obese Korean adults: the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV) 2009. Endocr J. 2013;60(5):679–686. doi: 10.1507/endocrj.ej12-0395
  29. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. doi: 10.1016/j.jamda.2011.01.003
  30. Mokrysheva NG, Krupinova YuA, Volodicheva VL, et al. A view at sarcopenia by endocrinologist. Osteoporosis and Bone Diseases. 2019;22(4):19–26. (In Russ). doi: 10.14341/osteo12465
  31. LeBlanc ES, Chou R. Vitamin D and falls-fitting new data with current guidelines. JAMA Intern Med. 2015;175(5):712–713. doi: 10.1001/jamainternmed.2015.0248. Erratum in: JAMA Intern Med. 2015;175(8):1426.
  32. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc. 2004;52(2):230–236. doi: 10.1111/j.1532-5415.2004.52060.x
  33. Zhao JG, Zeng XT, Wang J, Liu L. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017;318(24):2466–2482. doi: 10.1001/jama.2017.19344
  34. Kalyani RR, Stein B, Valiyil R, et al. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1299–1310. doi: 10.1111/j.1532-5415.2010.02949.x
  35. Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;(4):CD000227. doi: 10.1002/14651858.CD000227.pub4
  36. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327(23):1637–1642. doi: 10.1056/NEJM199212033272305
  37. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994;308(6936):1081–1082. doi: 10.1136/bmj.308.6936.1081
  38. Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med. 1998;338(8):485–492. doi: 10.1056/NEJM199802193380801
  39. Bonnick S, Broy S, Kaiser F, et al. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin. 2007;23(6):1341–1349. doi: 10.1185/030079907X188035
  40. McCloskey EV, Beneton M, Charlesworth D, et al. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res. 2007; 22(1):135–141. doi: 10.1359/jbmr.061008
  41. Reid IR, Horne AM, Mihov B, et al. Fracture Prevention with Zoledronate in Older Women with Osteopenia. N Engl J Med. 2018; 379(25):2407–2416. doi: 10.1056/NEJMoa1808082
  42. Cauley JA, Robbins J, Chen Z, et al.; Women’s Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA. 2003;290(13):1729–1738. doi: 10.1001/jama.290.13.1729
  43. Reid IR, Bolland MJ. Calcium and/or Vitamin D Supplementation for the Prevention of Fragility Fractures: Who Needs It? Nutrients. 2020;12(4):1011. doi: 10.3390/nu12041011
  44. Lewis JR, Zhu K, Prince RL. Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res. 2012;27(3):719–722. doi: 10.1002/jbmr.1484
  45. Reid IR, Birstow SM, Bolland MJ. Calcium and Cardiovascular Disease. Endocrinol Metab (Seoul). 2017;32(3):339–349. doi: 10.3803/EnM.2017.32.3.339
  46. Lima GA, Lima PD, Barros Mda G, et al. Calcium intake: good for the bones but bad for the heart? An analysis of clinical studies. Arch Endocrinol Metab. 2016;60(3):252–263. doi: 10.1590/2359-3997000000173
  47. Chiodini I, Bolland MJ. Calcium supplementation in osteoporosis: useful or harmful? Eur J Endocrinol. 2018;178(4):D13–D25. doi: 10.1530/EJE-18-0113
  48. Belaya ZhE, Belova KYu, Biryukova EV, et al. Osteoporosis: clinical guidelines. Moscow; 2021. 78 p. (In Russ).
  49. Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl. 1):1–46. doi: 10.4158/GL-2020-0524SUPPL
  50. Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44. doi: 10.1007/s00198-018-4704-5. Erratum in: Osteoporos Int. 2020;31(1):209. Erratum in: Osteoporos Int. 2020;31(4):801.
  51. Popova AYu, Tutelyan VA, Nikityuk DB. On the new (2021) Norms of physiological requirements in energy and nutrients of various groups of the population of the Russian Federation. Problems of Nutrition. 2021;90(4):6–19. (In Russ). doi: 10.33029/0042-8833-2021-90-4-6-19

Copyright (c) 2022 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies